Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis

Background: Chronic pulmonary diseases are characterized by airway remodeling due to complex multicellular responses and the production of free oxygen radicals. They lead to a progressive decline of pulmonary functions. Adelmidrol is an analogue of palmitoylethanolamide (PEA), which is a well-known...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusco, Roberta, Cordaro, Marika, Genovese, Tiziana, Impellizzeri, Daniela, Siracusa, Rosalba, Gugliandolo, Enrico, Peritore, Alessio Filippo, D’Amico, Ramona, Crupi, Rosalia, Cuzzocrea, Salvatore, Di Paola, Rosanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402091/
https://www.ncbi.nlm.nih.gov/pubmed/32660140
http://dx.doi.org/10.3390/antiox9070601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402091/
https://www.ncbi.nlm.nih.gov/pubmed/32660140
http://dx.doi.org/10.3390/antiox9070601

Ejemplares similares